🇺🇸 FDA
Patent

US 10913790

Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules

granted A61KA61K31/519A61K38/57

Quick answer

US patent 10913790 (Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules) held by The Regents of the University of Colorado, a Body Corporate expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/519, A61K38/57, A61K45/06, A61P